The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
rui ti pu mei yu niao ji mei zai ji xing xin ji geng si rong shuan zhi liao zhong de liao xiao fen xi
Author(s): 
Pages: 1241-1242
Year: Issue:  10
Journal: Research of Traditional Chinese Medicine

Keyword:  急性心肌梗死瑞替普酶尿激酶溶栓血管再通率;
Abstract: 目的观察国产重组组织型纤溶酶原激活剂(瑞替普酶)与尿激酶在急性心肌梗死(AMI)溶栓治疗中的疗效与安全性。方法将96例AMI患者随机分为瑞替普酶组(46例)和尿激酶组(50例),按临床间接指标判断溶栓冠脉血管再通率、住院期间死亡率及出血并发症。结果瑞替普酶组临床溶栓冠脉血管再通率高于尿激酶组,差异有统计学意义(P<0.01);死亡率、出血并发症两组比较差异无统计学意义。结论国产瑞替普酶溶栓疗效优于尿激酶。
Related Articles
No related articles found